[1] [1] IMAGAWA A, HANAFUSA T, MIYAGAWA J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group[J]. N Engl J Med, 2000, 342(5): 301-307.

[2] [2] IMAGAWA A, HANAFUSA T, AWATA T, et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus[J]. J Diabetes Invest, 2012, 3(6): 536-539.

[4] [4] IMAGAWA A, HANAFUSA T, UCHIGATA Y, et al. Fulminant type 1 diabetes: a nationwide survey in Japan[J]. Diabetes Care, 2003, 26(8): 2345-2352.

[5] [5] SONG S O, YUN J S, KO S H, et al. Prevalence and clinical characteristics of fulminant type 1 diabetes mellitus in Korean adults: a multi-institutional joint research[J]. J Diabetes Invest, 2022, 13(1): 47-53.

[6] [6] LUO S M, ZHANG Z Y, LI X, et al. Fulminant type 1 diabetes: a collaborative clinical cases investigation in China[J]. Acta Diabetol, 2013, 50(1): 53-59.

[7] [7] LI Z Q, ZHANG J P. The prevalence and clinical features of fulminant type 1 diabetes[J]. Chin J Intern Med, 2016, 55(11): 849-853.

[10] [10] TANAKA S, NISHIDA Y, AIDA K R, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes[J]. Diabetes, 2009, 58(10): 2285-2291.

[11] [11] LIU L, MAO J P, LU Z Y, et al. Clinical analysis of fulminant type 1 diabetes in China and comparison with a nationwide survey in Japan[J]. Ann Endocrinol (Paris), 2013, 74(1): 36-39.

[12] [12] WANG Z, ZHENG Y, TU Y T, et al. Immunological aspects of fulminant type 1 diabetes in Chinese[J]. J Immunol Res, 2016, 2016: 1858202.

[18] [18] LIU L, JIA W J, WU Y X, et al. Plasma glucose to glycated hemoglobin ratio: method of differentiating fulminant type 1 diabetes from diabetic ketoacidosis[J]. Ann Endocrinol (Paris), 2019, 80(1): 16-20.

[19] [19] QIU J L, LI X, CHEN W, et al. The fulminant index: a method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis[J]. Diabetes Metab Res Rev, 2022, 38(3): e3501.